Show Summary Details
Page of

Autoimmune Hepatitisa 

Autoimmune Hepatitisa
Autoimmune Hepatitisa

Kymberly D. Watt

and Albert J. Czaja

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 04 December 2020

Autoimmune hepatitis is a self-perpetuating inflammation of the liver of unknown cause that is associated with autoantibodies, hypergammaglobulinemia, and interface hepatitis seen on histologic examination. Autoimmune hepatitis afflicts 100,000 to 200,000 persons in the United States annually and accounts for 5.9% of liver transplants performed in the United States. The cause of autoimmune hepatitis is unknown. Multiple agents have been implicated as triggers of the disease, including certain viruses (hepatitis A, hepatitis B, hepatitis C, Epstein-Barr, herpes simplex, and measles viruses) and drugs (diclofenac, isoniazid, ?-methyldopa, minocycline, nitrofurantoin, atorvastatin, and propylthiouracil; recently, infliximab and adalimumab have been implicated). Hepatitis A virus infection and minocycline have been implicated most often worldwide. Most cases have no identifiable trigger.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.